1. Home
  2. NCNA vs BHAT Comparison

NCNA vs BHAT Comparison

Compare NCNA & BHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCNA
  • BHAT
  • Stock Information
  • Founded
  • NCNA 1997
  • BHAT 2010
  • Country
  • NCNA United Kingdom
  • BHAT China
  • Employees
  • NCNA N/A
  • BHAT N/A
  • Industry
  • NCNA Biotechnology: Pharmaceutical Preparations
  • BHAT Recreational Games/Products/Toys
  • Sector
  • NCNA Health Care
  • BHAT Consumer Discretionary
  • Exchange
  • NCNA Nasdaq
  • BHAT Nasdaq
  • Market Cap
  • NCNA 15.4M
  • BHAT 12.7M
  • IPO Year
  • NCNA 2017
  • BHAT 2019
  • Fundamental
  • Price
  • NCNA $3.44
  • BHAT $1.61
  • Analyst Decision
  • NCNA Buy
  • BHAT
  • Analyst Count
  • NCNA 2
  • BHAT 0
  • Target Price
  • NCNA $5,000.00
  • BHAT N/A
  • AVG Volume (30 Days)
  • NCNA 733.3K
  • BHAT 51.9K
  • Earning Date
  • NCNA 08-20-2025
  • BHAT 04-30-2025
  • Dividend Yield
  • NCNA N/A
  • BHAT N/A
  • EPS Growth
  • NCNA N/A
  • BHAT N/A
  • EPS
  • NCNA N/A
  • BHAT N/A
  • Revenue
  • NCNA N/A
  • BHAT $18,724,190.00
  • Revenue This Year
  • NCNA N/A
  • BHAT N/A
  • Revenue Next Year
  • NCNA N/A
  • BHAT N/A
  • P/E Ratio
  • NCNA N/A
  • BHAT N/A
  • Revenue Growth
  • NCNA N/A
  • BHAT N/A
  • 52 Week Low
  • NCNA $3.05
  • BHAT $1.56
  • 52 Week High
  • NCNA $1,856.00
  • BHAT $65.00
  • Technical
  • Relative Strength Index (RSI)
  • NCNA 30.79
  • BHAT 37.14
  • Support Level
  • NCNA $3.05
  • BHAT $1.56
  • Resistance Level
  • NCNA $3.78
  • BHAT $1.78
  • Average True Range (ATR)
  • NCNA 0.82
  • BHAT 0.08
  • MACD
  • NCNA 0.11
  • BHAT -0.01
  • Stochastic Oscillator
  • NCNA 5.61
  • BHAT 18.25

About NCNA NuCana plc

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.

About BHAT Blue Hat Interactive Entertainment Technology

Blue Hat Interactive Entertainment Technology is focused on commodity trading, including chemicals, jewelry, and precious metals such as gold. It operates a gold and diamond trading and supply chain business. Its business model encompasses physical gold trading, diamond trading, gold derivatives trading, and the development of AI-enabled trading platforms. Its segments include Diamond trading, Commodity trading, Information service, Interactive toys - animation series, and Interactive toys - game series. It derives revenue from Diamond trading. The majority of its revenues are generated in PRC.

Share on Social Networks: